Literature DB >> 1369369

Factor(s) required by EBV transformed lymphocytes to grow under limiting dilution conditions.

C Negri1, R Chiesa, G C Ricotti.   

Abstract

IL-6 was demonstrated to promote growth of EBV transformed lymphocytes. However IL-6 was ineffective at promoting growth of EBV transformed lymphocytes cultured at the single cell level under limiting dilution conditions. On the contrary, HECS, which is known to contain IL-6, supported very efficiently the growth of 1-2 EBV transformed cells. When IL-6 was removed from HECS, by using specific antibodies, no reduction in HECS activity was observed, indicating that probably more than one growth factor is required to support the growth of EBV transformed cells cultured at very low cell numbers in the absence of feeder cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1369369     DOI: 10.1007/bf00365928

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  19 in total

1.  Carboxyethyl gamma-aminobutyric acid, a polyamine derivative, improves the recovery of EBV-transformed lymphocytes.

Authors:  A Cerino; M Bestagno; M Colonna; F Fussi; G C Astaldi Ricotti
Journal:  Biochem Biophys Res Commun       Date:  1988-02-15       Impact factor: 3.575

2.  Requirements for growth of Epstein-Barr virus-transformed cells at low cell densities.

Authors:  R F Tiebout; R W Sauerwein; W G van der Meer; F van Boxtel-Oosterhof; W P Zeijlemaker
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

3.  IL-1 stimulates IL-6 production in endothelial cells.

Authors:  M Sironi; F Breviario; P Proserpio; A Biondi; A Vecchi; J Van Damme; E Dejana; A Mantovani
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

4.  Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens.

Authors:  U Landegren
Journal:  J Immunol Methods       Date:  1984-03-16       Impact factor: 2.303

5.  Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique.

Authors:  D Kozbor; J C Roder
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

6.  Clonal analysis of a human lymphoblastoid cell line (B17) secreting antibody to N-acetyl-D-glucosamine.

Authors:  C Polke; B Greger; M Steinitz; K Eichmann
Journal:  Immunobiology       Date:  1982-10       Impact factor: 3.144

7.  Molecular cloning and expression of hybridoma growth factor in Escherichia coli.

Authors:  J P Brakenhoff; E R de Groot; R F Evers; H Pannekoek; L A Aarden
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

8.  Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor.

Authors:  H Wakasugi; L Rimsky; Y Mahe; A M Kamel; D Fradelizi; T Tursz; J Bertoglio
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

9.  Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line.

Authors:  G Scala; G Morrone; M Tamburrini; F Alfinito; C I Pastore; G D'Alessio; S Venuta
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

10.  Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus.

Authors:  J Gordon; S C Ley; M D Melamed; P Aman; N C Hughes-Jones
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

View more
  3 in total

1.  Effect of endogenous proteins on growth and antibody productivity in hybridoma batch cultures.

Authors:  P J Farrell; N Kalogerakis; L A Behie
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

2.  Correction of the neuropathogenic human apolipoprotein E4 (APOE4) gene to APOE3 in vitro using synthetic RNA/DNA oligonucleotides (chimeraplasts).

Authors:  Aristides D Tagalakis; J George Dickson; James S Owen; J Paul Simons
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  Distinct ex vivo susceptibility of B-cell subsets to epstein-barr virus infection according to differentiation status and tissue origin.

Authors:  Marcus Dorner; Franziska Zucol; Christoph Berger; Rahel Byland; Gregory T Melroe; Michele Bernasconi; Roberto F Speck; David Nadal
Journal:  J Virol       Date:  2008-03-05       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.